LIFESTYLE GENERALITIES THAT CAN HELP TO BETTER CONTROL CACHEXIA
1. Exercises, walking, 20 minutes of sunlight over body = 20,000 vitamin D units. Our immune cells have the most vitamin D receptors.
2. Good sleep, early, favors Human Growth (HG) hormone and anti oxydant melatonin.
3. Eating many smaller meals within a narrow window during the day, based on a mostly plant based high fat diet, though some exceptions can be made.
4. Hydrating well to help eliminate tumor lysis (tumor debris and dieoff) and kidney-liver support.
5. Anemas to help with both dieoff elimination and cachexia.
6. Detox and heat with saunas
SPECIFIC APPROACHES THAT TARGET CACHEXIA PATHWAYS
1. MCT and krill oil. With occasional fish, garlic and some extra Selenium. Polyunsaturated fatty acids (n-3 PUFA).
5. MSM with vitamin C.
7. Cannabinoids (sativa and more CBDs).
8. Testosterone, bio-identical and-or via sunlight. Oxandrolone, a modified testosterone derivative, has been used as an oral anabolic agent for both men and women with weight loss associated with surgery, infection and other catabolic conditions including cancer cachexia.
9. Progesterone bio-identical cream
10. D-Ribose, with pickle juice, MSM and vitamine C.
11. Aloe and honey, with avocado to slow down sugar level.
13. Lipoic acid, Meyers cocktail (with GSH).
17. Green tea
18. Glutamine and Arginine rich foods, but strategically prepared in order not to fuel cancer’s growth.
19. Hydroxine Sulphate. Caution with Vitamin C and potassium.
“Hydrazine sulfate was evaluated using 24-hour dietary recalls and body weight determinations before and after 30 days of either placebo or hydrazine (60 mg, 3 times/d) oral administration in 101 heavily pretreated cancer patients with weight loss. After 1 month, 83% of hydrazine and only 53% of placebo patients completing repeat evaluation maintained or increased their weight (P less than 0.05). In addition, appetite improvement was more frequent in the hydrazine group (63% versus 25%, P less than 0.05). Although caloric intake was only slightly greater in hydrazine-treated patients, an increased caloric intake was more commonly associated with weight gain in patients receiving hydrazine compared with those receiving placebo (81% versus 53%, respectively). Hydrazine toxicity was mild, with 71% of patients reporting no toxic effects. Hydrazine sulfate circulatory levels were obtained from a subset of 14 patients who completed 30 days of treatment, with a single sample obtained in the morning at least 9 hours after the last dose. Mean maintenance hydrazine sulfate levels, determined using a spectrofluorometric assay, ranged from 0 to 89 ng/ml (mean 45 +/- 16 ng/ml). These data, which demonstrate an association between 1 month of hydrazine sulfate administration and body weight maintenance in patients with cancer, suggest future clinical trials of hydrazine sulfate are indicated to definitively assess its long-term impact on important clinical outcome parameters in defined cancer populations.”
Chlebowski RT, Bulcavage L, Grosvenor M, Tsunokai R, Block JB, Heber D, Scrooc M, Chlebowski JS, Chi J, Oktay E, et al., Hydrazine sulfate in cancer patients with weight loss. A placebo-controlled clinical experience, Cancer. 1987 Feb 1;59(3):406-10.
For the ACR Institute’s full report on cachexia control and reversal, click here.
Disclaimer: Nothing in this educational blog should be construed as medical advise
2016 (c). Advanced Cancer Research Institute and agents. All Rights reserved